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INTRODUCTION
Neural precursors isolated from the embryonic central ner-
vous system (CNS) can be expanded in vitro and be differenti-
ated into various neuronal and glial subtypes in vitro and in 
vivo (Davis and Temple, 1994; Brustle et al., 1997). Studies 
on CNS precursor cells provide a valuable tool for probing 
brain development and for developing a renewable source 
of specialized neurons for cell replacement strategies (Park 
et al., 2006). Many issues still must be resolved before ap-
plying stem cell therapy in the clinic, including low cell viabil-
ity, difficulty of tracking stem cell differentiation, and low cell 
engraftment after transplantation (Arvidsson et al., 2002; Ya-
mashita et al., 2006). To address the stem cell differentiation 
tracking problem, we developed a Synapsin reporter system 
to enhance the identification, sorting, and tracking of mature 
neurons. SYNAPSIN is a family of neuron-specific phospho-
proteins that selectively bind to small synaptic vesicles (Thiel 
et al., 1991), and SYNAPSIN expression is one of the most 
frequently used markers for confirming mature neurons (Ku-
gler et al., 2001). Previous studies have reported the use of 
a Synapsin promoter to drive the expression of a reporter 
gene from the predicted Synapsin promoter or by fusion with 
a reporter gene (Kugler et al., 2003). To date, many studies 
have been carried out to detect the transplanted cells them-
selves after neural precursor cell transplantation; however, no 
method has been reported to observe neuronal differentiation 
in vivo. In this study, we aimed to establish a system to track 
neuronal differentiation in vivo.
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Cell therapeutic agents for treating degenerative brain diseases using neural stem cells are actively being developed. However, 
few systems have been developed to monitor in real time whether the transplanted neural stem cells are actually differentiated into 
neurons. Therefore, it is necessary to develop a technology capable of specifically monitoring neuronal differentiation in vivo. In 
this study, we established a system that expresses cell membrane-targeting red fluorescent protein under control of the Synapsin 
promoter in order to specifically monitor differentiation from neural stem cells into neurons. In order to overcome the weak expres-
sion level of the tissue-specific promoter system, the partial 5’ UTR sequence of Creb was added for efficient expression of the 
cell surface-specific antigen. This system was able to track functional neuronal differentiation of neural stem cells transplanted in 
vivo, which will help improve stem cell therapies.
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MATERIALS AND METHODS
Isolation and culture of primary mouse NPCs
Animals were housed and treated according to the guide-
lines of the Institutional Animal Care and Use Committee (IA-
CUC-2016-0084A) of Hanyang University, Korea. Cultures of 
mouse neural precursor cells (NPCs) derived from mouse em-
bryonic brains were performed as described previously (Park 
et al., 2008) with some modifications. NPCs were obtained 
from the cortex of Imprinting Control Region (ICR) mice at em-
bryonic day 12 (DaeHan BioLink, Seoul, Korea). Mouse NPCs 
dissociated from the cortex tissue were cultured at 20,000 
cells/cm2 on a dish pre-coated with 15 µg/mL poly-l-ornithine 
(Sigma-Aldrich, St. Louis, MO, USA) and 1 µg/mL fibronectin 
(Sigma-Aldrich). For proliferation, the mouse NPCs were incu-
bated in proliferation medium comprising N2 medium (DMEM/
F12, 4.4 µM insulin, 100 mg/L transferrin, 30 nM selenite, 0.6 
µM putrescine, 20 nM progesterone, 200 mM L-glutamine, 8.6 
mM D(+) glucose, 20 mM NaHCO3 [Invitrogen, Carlsbad, CA, 
USA]) supplemented with 20 ng/mL basic fibroblast growth 
factor (bFGF; R&D Systems, Minneapolis, MN, USA), 20 ng/
mL epidermal growth factor (EGF; R&D Systems), and B-27 
Supplement without Vitamin A (Invitrogen) at 37°C, 5% CO2. 
For differentiation, the NPCs were incubated in differentiation 
medium, comprising N2 medium supplemented with 0.2 mM 
ascorbic acid (AA; Sigma-Aldrich), 20 ng/mL brain-derived 
neurotrophic factor (BDNF; PeproTech, Rocky Hill, NJ, USA), 
20 ng/mL glial cell line derived neurotrophic factor (GDNF; 
Peprotech), 250 µg/mL dibutyryl-cyclic AMP (cAMP; Sigma-
Aldrich), and/or B-27 Supplement (Invitrogen) at 37°C in a 5% 
CO2 incubator. Medium was changed every other day and mi-
togens were added daily.
Plasmid construction
pLVX-CherryPicker2 vector (Clontech, Mountain View, CA, 
USA) was used for constructing plasmid backbones. CMV IE 
promoter+multiple cloning site+internal ribosome entry site 
of pLVX-CherryPicker2 vector were replaced by the following 
four types. 1) S; Human Synapsin promoter (pSYN, from Gen-









gagtcgtgtcgtgcctgagagcgcagtcggga), 2) S5; pSYN+partial 5′ 
untranslated region of rat cAMP response element-binding 











tacgtattagtcatcgctatta) and 4) cS5; pCMVE IE+pSYN+Creb 5′ 
UTR), respectively. Each sequence was amplified using High 
fidelity taq polymerase (Invitrogen) and cloned into pGEM T-
Easy (Promega, Madison, WI). pLVX-CherryPicker2 lentiviral 
vectors harboring these sequences were generated by insert-
ing the appropriate restriction enzyme fragments derived from 
each of the pGEM T-Easy intermediates. As a result, the vec-
tors CherryPicker-LV2S, CherryPicker-LV2S5, CherryPicker-
LV2cS, and CherryPicker-LV2cS5 were constructed.
Lentiviral production and transduction
The lentiviruses were produced from 293T cells with pack-
aging plasmids (pLP1, pLP2, pLP-VSVG, Clontech). Trans-
fection was performed by reacting the lentiviral plasmids and 
Lipofectamine2000 reagent (Invitrogen). The supernatants 
containing lentiviral particles were harvested after 24 h of 
transfection. The viral supernatants were concentrated using 
ultracentrifugation (Optima XL-I, Beckmen, CA, USA). The 
concentrated supernatants were transduced to mouse NPCs 
in the presence of polybrene (1 µg/mL, hexadimethrine bro-
mide: Sigma-Aldrich) for 24 h in the proliferation medium.
Immunocytochemistry
Cultured cells were fixed using 4% paraformaldehyde (Sig-
ma-Aldrich), and the fixed cells were blocked using 0.1% bo-
vine serum albumin (BSA)/phosphate-buffered saline (PBS), 
10% normal goat serum (NGS; Pel-Freez, Rogers, AR, USA), 
and 0.3% Triton X 100 (Sigma-Aldrich) for 1 h. The blocked 
cells were incubated with the following primary antibodies 
at 4°C overnight: rabbit anti-TUJ1 (1:2000, Covance, Rich-
mond, CA, USA), rabbit anti-red fluorescent protein (RFP; 
1:500, Rockland, Limerick, PA, USA), mouse anti-SYNAP-
SIN1 (1:500, BD Biosciences, San Jose, CA, USA). The next 
day, the cells were incubated with Alexa 488- (Invitrogen), 
Rhodamine-, or Cy3- (Vector Laboratories, Burlingame, CA, 
USA) conjugated secondary antibodies. Cells were mounted 
in VECTASHIELD with 4′,6-diamidino-2-phenylindole (DAPI; 
Vector Laboratories) and observed and photographed under 
a fluorescent microscope (LEICA Microsystem, Wetzler, Ger-
many).
In vivo cell transplantation
The adult ICR mice (6-wk old; Orient, Seongnam, Korea) 
were anesthetized with ketamine (100 mg/kg; Huons, Gyeong-
gi, Korea) and xylazine (10 mg/kg; Bayer Korea, Seoul, Korea) 
by intraperitoneal injection. The mice received an intracortical 
and intrastriatal injection of mouse NPCs (5.0×105 cells/5 µL 
volume, 0.01 µL/s infusion rate) using stereotaxic coordinates 
(cortex: AP +0.5 mm from bregma; ML –1.7 mm from bregma; 
DV –1.5 mm from dura and striatum: AP +0.5 mm from breg-
ma; ML –1.7 mm from bregma; DV –3.5 mm from dura). Body 
temperature was maintained at 37°C in a heating chamber 
during the recovery period.
Histological procedures
Animals were sacrificed under ketamine (100 mg/kg; i.p.) 
and xylazine (10 mg/kg; i.p.) anesthesia and given an intracar-
dial perfusion of 4% paraformaldehyde, then the brains were 
harvested and cryosectioned with a slice thickness of 16 µm. 
Individual sections were stained using rabbit anti-red fluores-
cent protein (RFP; 1:500, Rockland, Limerick, PA, USA). The 
sections were incubated with Alexa Fluor R 594 (1:400, Invit-
rogen), secondary antibodies, then covered with Vectashield 
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R mounting medium with DAPI. The stained sections were 
then assessed by confocal imaging (LSM700, Zeiss, Gottin-
gen, Germany). 
Cell counting and statistical analysis
Cell counting was conducted in 5-10 microscopic fields per 
well, with three wells per experimental condition. All experi-
ments were conducted in triplicate. Data are expressed as the 
mean ± SEM. When more than two groups were compared, a 
paired t-test was performed using SigmaPlot for windows, ver-
sion 10.0 (Systat Software GmbH, Erkrath, Germany).
RESULTS
Optimization of efficient NSC differentiation niches in 
vitro
Using previously developed mouse primary NPCs isola-
Biomol  Ther 27(1),  78-84 (2019)

























































Fig. 1. Component selection for efficient in vitro differentiation of NPCs into neurons. Immunostaining of mouse NPCs at day 14 of differenti-
ation. Neurons were determined by the expression of TUJ1 and SYNAPSIN1. AA- and B27-treated NPCs were used as the negative control, 
and the NPCs treated with a cytokine mixture (AA, BDNF, GDNF, DX, cAMP, B27) were used as the positive control. (A) Each negative con-
trol was respectively added, and the differentiation-related cytokines (BDNF, GDNF, DX, cAMP) were evaluated. (B) For the positive control, 
each differentiation-related cytokine (BDNF, GDNF, DX, cAMP) was respectively eliminated. (C) Counts of TUJ1+ or SYNAPSIN1+ neuronal 
cells at 14 days post-induction with differentiation-related cytokines are shown in panel A. (D) Counts of TUJ1+ or SYNAPSIN1+ neuronal 
cells at 14 days post-induction with differentiation-related cytokines are shown in panel B. Error bars, SE. *p<0.05, Scale bar, 50 µm.
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tion (Park et al., 2008) and differentiation (Chambers et al., 
2009) protocols, the critical role of various cytokines (AA, 
BDNF, GDNF, cAMP, B-27 supplement, and doxycycline) dur-
ing NPC differentiation into neurons was established. Con-
sequently, we tested a more efficient differentiation cytokine 
mixture and determined the key cytokine(s) contributing to dif-
ferentiation. Neuronal differentiation was conducted in NPCs 
cultured in conditioned medium supplemented with AA and 
B-27 supplement. To determine the key cytokine, NPCs were 
also differentiated in media containing individual cytokines. 
Mouse NPCs were cultured in the differentiation medium for 
14 days and identified with immunofluorescence analysis (Fig. 
1A). Neurons were monitored according to the expression of 
TUJ1 and SYNAPSIN1, an early neuronal marker and marker 
of differentiated neurons, respectively. Only cAMP treatment 
greatly increased the efficiency of neuronal differentiation to 
>50% of all cells, compared with a rate of <20% TUJ1+ cells 
detected when the other individual cytokines were used alone 
(Fig. 1C). In addition, an efficient differentiation cytokine mix-
ture was determined using various cytokines while eliminat-
ing each cytokine one at a time. As a result, the number of 
neurons increased upon treatment with various cytokines (Fig. 
1B). However, the removal of cAMP decreased the efficiency 
of neuron differentiation with <10% TUJ1+ of all cells, com-
pared with >50% TUJ1+ cells when all cytokines were used. 
In addition, we found the cytokine mixture lacking doxycycline 
showed greatly increased differentiation efficiency with >75% 
neurons of all cells compared with >50% TUJ1+ cells when all 
cytokines were used (Fig. 1D). These results showed that an 
efficient differentiation cytokine mixture and cAMP play a criti-
cal role in promoting neuronal differentiation in NPC culture.
Neuronal differentiation-specific surface protein 
expression in vitro
Previous studies have reported the use of a Synapsin pro-
moter as a neuronal marker. We developed several vectors for 
neuron-specific identification based on pLVX-CherryPicker2, a 
self-inactivating lentivirus derived from HIV-1. We replaced the 
CMV IE promoter region of pLVX-CherryPicker2 to the human 
Synapsin promoter. SYNAPSIN1 is a family of neuron-specific 
phosphoproteins that selectively bind to small synaptic vesi-
cles. In addition, we enhanced Synapsin promoter function for 
specific expression using partial 5′ UTR region of Creb and a 
CMV enhancer. Four constructs were created based on the 
expression of a membrane-targeted RFP (CHERRYPICKER) 
under the control of the Synapsin promoter (pSYN-RFP). First, 
a construct was created by inserting the Synapsin promoter in 
front of the CherryPicker gene (CherryPicker-LV2S). Second, 
the pSYN-RFP construct was created by inserting partial 5′ 
UTR region of Creb (CherryPicker-LV2S5). Third, the pSYN-
Fig. 2. Identification of the pSYN-RFP reporter system of neural stem cells. (A) Schematic of the construction of the human Synapsin 
promoter-driven CherryPicker reporter constructs. (B) Representative images of neuronal cultures transduced with four lentiviral vectors of 
hSYN-RFP and immunostained with RFP; mouse NPCs were differentiated into neurons for 1 and 14 days. The RFP protein transduced by 















































RFP construct was created by inserting the pCMV enhanc-
er (CherryPicker-LV2cS). Finally, the pSYN-RFP construct 
was created by inserting partial 5′ UTR region of Creb and 
the pCMV enhancer (CherryPicker-LV2cS5, Fig. 2A). Mouse 
NPCs were transduced with the four pSYN-RFP construct 
plasmids by lentivirus, respectively, differentiated to neurons 
for 14 days, and identified with immunofluorescence analysis. 
All four constructs of pSYN-RFP mouse NPCs were positive 
for RFP, indicating that the pSYN-RFP reporter system was 
working properly. However, pSYN-RFP showed significantly 
weaker gene expression in differentiated mouse NPCs com-
pared with expression in proliferating NPCs. Consequently, 
gene expression increased according to the concentration of 
lentivirus using successive rounds of ultracentrifugation with 
high-titer viral preparations (Ichim and Wells, 2011). Among 
the four constructs, CherryPicker-LV2S5 showed a particu-
larly high titer and specific expression. When NPCs were dif-
ferentiated into neurons for 14 days with CherryPicker-LV2S5, 
immunofluorescence analysis showed no RFP expression at 
day 0 (prior to differentiation); however, beginning at day 3, 
several cells began to express RFP, and its expression lev-
el increased as differentiation progressed. Interestingly, the 
RFP-positive cells in differentiating NPCs mostly overlapped 
with SYNAPSIN1 and TUJ1+ cells (Fig. 3A, 3B). At 1 day of 
differentiation, there were <5% RFP+ cells among total cells, 
which increased to >50% RFP+ cells at 14 days (Fig. 2B). The 
CherryPicker-LV2cS5 transduced NPCs expressed a high titer 
of RFP; however, their morphology was immature due to the 
non-specific driving force of the pCMV enhancer. Therefore, 
we selected the CherryPicker-LV2S5 construct for a neuronal 
differentiation-specific RFP expression vector.
Differentiation-specific surface protein expression in vivo
We identified that the pSYN-RFP reporter system was 
working properly in vivo by transplanting pSYN-RFP NPCs 
into a mouse model. Immunofluorescence analysis showed 
RFP expression in xenografts at 2 days and 7 days after trans-
plantation (Fig. 3C). Similar to in vitro expression patterns, in 
vivo transplanted NPCs did not express RFP at day 2; how-
ever, RFP was expressed at day 7 of transplantation.
DISCUSSION
A variety of stem cell therapies have been applied in the 
clinic. However, it is difficult to evaluate the role of transplanted 
stem cells because it is difficult to determine if the stem cells 
injected into patients function in vivo. In the case of stem cell 
therapy for degenerative brain diseases, it has been reported 
that the transplanting committed neural precursor cells is more 
effective than transplanting fully differentiated neuronal cells 
(Park et al., 2005). In the case of transplanting neural precur-
sor cells, the transplanted neural precursor cells are observed 
through tissue staining at the expense of the transplanted ani-










































*D0 D1 D14 D14
TUJ1/RFP SYNAPSIN/RFPTUJ1/RFP TUJ1/RFP
Fig. 3. pSYN-RFP reporter system in vitro and in vivo. (A) Co-immunostaining of RFP and TUJ1, and of RFP and SYNAPSIN1 at days 0, 
1, and 14, indicating their overlap in the TUJ1+ and SYNAPSIN1+ neurons. (B) Proportions of positive cells (TUJ1 or RFP) counted on days 
1 and 14 of differentiation. (C) Identification of striatum tissue on days 2 and 7 post-transplantation. Similar to in vitro findings, in vivo trans-
planted NPCs did not express RFP at the early stage of differentiation; however, red-colored mature neuronal morphology was observed at 
day 7 of differentiation. Error bars, SE. *p<0.05. Scale bar, 50 µm.
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mals in order to confirm the differentiation into functional neu-
rons. When NPCs transfected with magnetic nanoparticles 
are transplanted, the distribution of the transplanted NPCs in 
vivo can be observed by magnetic resonance imaging (MRI). 
However, whether or not the transplanted neural progenitor 
cells have been differentiated into functional neurons has not 
yet been reported by MRI observation. This may be due to 
the absence of cell surface antigens that can specifically track 
differentiated neurons. In this study, we established a platform 
for monitoring neurons that specifically express cell surface 
antigens in differentiated neurons.
First, the most effective differentiation cytokine mixture was 
determined during the differentiation of NPCs into neurons. 
The most effective combination of cytokines for differentiation 
was determined as AA, BDNF, GDNF, cAMP, and B-27 supple-
ments, and TUJ1 and SYNAPSIN expression were used as 
neuronal differentiation markers. We also found that cAMP is 
the most important factor for inducing neurons. This is consis-
tent with reports that the transcription factor CREB is involved 
in several aspects of neuronal development (Giachino et al., 
2005). In addition, doxycycline directly inhibits the PI3K-AKT 
pathway, which is associated with cell survival but inhibits dif-
ferentiation (Singh et al., 2012; Chang et al., 2014), and since 
doxycycline interferes with the neuronal differentiation of 
NPCs, it was excluded from the cytokine combination.
Next, the CherryPicker gene used in this construct is a fu-
sion protein composed of the fluorescent protein mCHERRY 
and the transferrin receptor membrane anchor domain (Sha-
ner et al., 2004). As a result, CHERRYPICKER protein is 
expressed on the cell surface. CHERRYPICKER has been 
applied to overcome the limitations of conventional in vivo 
transplanted stem cell detection systems using MRI because 
it acts as a surface antigen for the anti-RFP antibody as a 
targeting tool for neurons. This protein enables the in vivo 
monitoring of neurons by combining Fe3O4 with this antibody 
(Sohn et al., 2015). In addition, the SYNAPSIN protein is a 
differentiation-specific protein that is expressed when NPCs 
differentiate into neurons. The SYNAPSIN protein begins to 
be expressed 3 to 5 days after neural differentiation and is 
expressed thereafter (Kugler et al., 2001). By applying the 
CHERRYPICKER protein to the SYNAPSIN protein expres-
sion pattern, the CHERRYPICKER protein can be specifically 
expressed on the neuronal surface. Therefore, we have estab-
lished a system in which CHERRYPICKER protein expression 
is induced by the Synapsin promoter.
In the case of tissue-specific promoters, it is known that the 
protein expression intensity is weak. The Synapsin promoter 
vector, which is generally used, has been used in combination 
with the CMV enhancer sequence to enhance the expression 
potential of the Synapsin promoter. The CMV enhancer can 
promote the strong expression of an exogene, but because it 
expresses the exogene in all cells, it has low specificity for the 
Synapsin promoter and the exogene can be expressed in cells 
other than neurons. In this study, we used a partial sequence 
of the 5′ UTR region of the Creb gene to increase exogene 
expression while maintaining the specificity of the Synapsin 
promoter. Four vectors were constructed by combining each 
sequence of the CMV enhancer, Synapsin promoter, and the 
5′ UTR of Creb. As a result, the Synapsin promoter+5′ UTR of 
Creb construct (CherryPicker-LV2S5) was used to express the 
CHERRYPICKER protein specifically in neurons.
In vitro, CHERRYPICKER protein was not expressed during 
proliferation or at the early stage of neuronal differentiation but 
was expressed on the surface of neurons upon the progres-
sion of neuronal differentiation and was persistently expressed 
after 7 days of neuronal differentiation. NPCs transduced with 
CherryPicker-LV2S5 were transplanted into mouse striatum 
and stained 2 and 7 days after transplantation. Similar to the in 
vitro results, the expression of CHERRYPICKER protein was 
not observed on the second day of transplantation, but on the 
7th day of transplantation, the CHERRYPICKER protein was 
fully expressed on neuronal surfaces. These results show that 
our system worked properly not only in vitro but also in vivo.
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